Systematic Targeting Of MicroPlastics (STOMP)

The ARPA‑H solicitation (ARPA‑H‑SOL‑26‑152 “STOMP”) seeks proposals to execute Task Area 1 (TA1) – development of a clinical system/assay – and, in a future solicitation, Task Area 3 (TA3) – development of a removal system. Proposals must follow the Preliminary Task Description Document (TDD) format, providing a concise one‑page background and scope narrative that outlines the program’s vision, current state‑of‑the‑art, market potential, and transition/commercialization goals. Each offer must include a detailed risk‑mitigation/contingency plan, a one‑page Gantt chart, a one‑page commercialization plan (with draft revisions due by Month 24 for TA1 and Month 48 for TA3), and a capabilities/management summary of the prime team and any sub‑awardees. Cost proposals should present estimated totals and material categories now, with a fully detailed cost breakdown required during negotiations; all labor, material, equipment, travel, and sub‑award costs must be substantiated and evaluated for reasonableness. Unique to this effort is the explicit requirement to embed commercialization strategy from proposal inception, identify prospective transition partners, and address market access, scalability, and sustainability throughout the project lifecycle.

Notice ID

b7338e41ddbf4ba78ba4507bc46198e8

Solicitation Number

ARPA-H-SOL-26-152

NAICS Code

541714

Classification Code

AN13